会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • SUBSTITUTED N-ARYLSULFONYLHETEROCYCLIC AMINES AS GAMMA-SECRETASE INHIBITORS
    • 作为GAMMA-分泌酶抑制剂的取代的N-芳基磺酰氧基化胺
    • WO2006004880A3
    • 2007-03-08
    • PCT/US2005023187
    • 2005-06-28
    • SCHERING CORPJOSIEN HUBERT BCLADER JOHN WBARA THOMAS AXU RUOLI HONGMEIPISSARNITSKI DMITRIZHAO ZHIQIANG
    • JOSIEN HUBERT BCLADER JOHN WBARA THOMAS AXU RUOLI HONGMEIPISSARNITSKI DMITRIZHAO ZHIQIANG
    • C07D265/30A61K31/5377A61P25/28C07D413/12C07D451/02C07D487/08
    • C07D265/30C07D413/12C07D451/02C07D487/08
    • This invention discloses novel gamma secretase inhibitors of the formula I: wherein: L is -O- , -N(R 6 )-, -S-, -S(O)-, or -S(O 2 )-; R 1 is selected from the group consisting of aryl and heteroaryl; R 2 is selected from the group consisting of alkyl, -C(O)-Y, -X-C(O)-Y, -alkylene-X-C(O)-Y, -alkylene-C(O)-Y, -alkylene-cycloalkylene-X-C(O)-Y, -alkylene-cycloalkylene-C(O)-Y, -cycloalkylene-alkylene-X-C(O)-Y, -cycloalkylene-alkylene-C(O)-Y, -cycloalkylene-X-C(O)-Y, -cycloalkylene-C(O)-Y, -alkylene-cycloalkylene-alkylene-X-C(O)-Y, -alkylene-cycloalkylene-alkylene-C(O)-Y, aryl, and heteroaryl; R 3 is selected from the group consisting of aryl, heteroaryl, alkyl, cycloalkyl, arylalkyl, arylcycloalkyl, heteroarylalkyl, heteroarylcycloalkyl, arylheterocycloalkyl, and alkoxyalkyl; each R 4 and R 5 is independently selected from the group consisting of H and alkyl; and Y is selected from the group consisting of -NR 8 R 9 , -N(R 6 )-(CH 2 ) b -NR 8 R 9 , aryl, heteroaryl, alkyl, cycloalkyl, arylalkyl, arylcycloalkyl, heteroarylalkyl, heteroarylcycloalkyl, and arylheterocycloalkyl; or Y is selected from the group consisting of Formula II and Formula III: One or more compounds of formula I, or formulations comprising such compounds, may be useful, e.g. in treating Alzheimer's Disease.
    • 本发明公开了式I的新型γ分泌酶抑制剂:其中:L是-O-,-N(R 6) - , - S - , - S(O) - 或-S( 0 2 ) - ; R 1选自芳基和杂芳基; R 2选自烷基,-C(O)-Y,-XC(O)-Y, - 亚烷基-XC(O)-Y, - 亚烷基-C(O )-Y-亚烷基 - 亚环烷基-OC(O)-Y-亚烷基 - 亚环烷基-C(O)-Y-亚烷基 - 亚烷基-OC(O)-Y-亚烷基 - 亚烷基-C(O) Y( - )亚环烷基-C(O)-Y-亚烷基-C(O)-Y-亚烷基 - 亚环烷基亚烷基-XC(O)-Y-亚烷基 - 亚环烷基 - 亚烷基-C(O)-Y, 芳基和杂芳基; R 3选自芳基,杂芳基,烷基,环烷基,芳基烷基,芳基环烷基,杂芳基烷基,杂芳基环烷基,芳基杂环烷基和烷氧基烷基; 每个R 4和R 5独立地选自H和烷基; 并且Y选自-NR 8 R 9,-N(R 6) - (CH 2) 芳基,杂芳基,烷基,环烷基,芳基烷基,芳基环烷基,杂芳基烷基,杂芳基环烷基和芳基杂环烷基 ; 或Y选自式II和式III的化合物:一种或多种式I化合物或包含该化合物的制剂可用于,例如, 治疗阿尔茨海默病。